Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Focus on anticoagulants].

G Montalescot1

  • 1Service de Cardiologie, Hôpital Pitié-Salpêtrière, Paris.

Annales De Cardiologie Et D'Angeiologie
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

The evolving landscape of anticoagulants, including heparins and Vitamin K antagonists, requires updated monitoring protocols. Codifying treatment ensures effectiveness and improves the risk/benefit ratio for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administration.

Xenobiotica; the fate of foreign compounds in biological systems·2025
Same author

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

NEJM evidence·2025
Same author

Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxia.

International journal of cardiology·2021
Same author

Unusual arterial thrombotic events in Covid-19 patients.

International journal of cardiology·2020
Same author

Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.

Annales de cardiologie et d'angeiologie·2020
Same author

[Coronary thrombosis: Physiopathology and treatment in the era of tailored medicine].

Annales de cardiologie et d'angeiologie·2017
Same journal

[Study of Sleep Apnea Syndrome in Patients with Chronic Heart Failure in the Cardiology Department at Yalgado Ouédraogo teaching hospital in 2024 and 2025].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Impact of knowledge and practices of hygieno-dietetical measures in hypertensive people at the Abidjan cardiology institute].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Dobutamine stress echocardiography: Appropriateness of indications and protocol compliance. A single-centre report].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Post-COVID postural orthostatic tachycardia syndrome: Documentation of a hyperadrenergic phenotype by comprehensive autonomic testing].

Annales de cardiologie et d'angeiologie·2026
Same journal

Urban-rural disparities in hypertension prevalence, screening, and control in South Kivu Province, eastern Democratic Republic of the Congo.

Annales de cardiologie et d'angeiologie·2026
See all related articles

Area of Science:

  • Pharmacology
  • Thrombosis Management

Context:

  • Increasing availability of heparins and low molecular weight heparins has altered prescribing practices.
  • Certain heparin-induced complications, such as thrombocytopenia and acute pulmonary hypertension, are not widely understood.
  • Vitamin K antagonists possess unique characteristics, including variable half-lives, necessitating specific knowledge.

Purpose:

  • To highlight the need for codified treatment monitoring for heparins to enhance efficacy and safety.
  • To emphasize the importance of understanding the specific properties of Vitamin K antagonists for effective use.
  • To address the dynamic nature of anticoagulant therapy and the anticipated emergence of novel antithrombotic agents.

Summary:

  • Heparin prescribing habits have shifted with the advent of low molecular weight heparins.

Related Experiment Videos

  • Complications like thrombocytopenia and pulmonary hypertension require better understanding and management.
  • Standardized monitoring for anticoagulants, including Vitamin K antagonists assessed by INR, is crucial for optimizing the risk/benefit profile.
  • The field of anticoagulation is rapidly evolving with new drugs on the horizon.

    • Impact:

    • Improved understanding and codified monitoring of anticoagulants can lead to increased treatment effectiveness.
    • Better management of heparin-related complications can reduce adverse events.
    • Ensuring prescribers are aware of drug-specific properties and monitoring parameters optimizes patient care.
    • Anticipating and adapting to new antithrombotic therapies is essential for future clinical practice.